BPDA2 is a highly selective and competitive SHP2 inhibitor, exhibiting IC50 values of 92.0 nM for SHP2, and 33.39 µM and 40.71 µM for SHP1 and SHP1B, respectively. This compound effectively downregulates mitogenic and cell survival signaling, including reducing expression of receptor tyrosine kinases (RTKs). Furthermore, BPDA2 suppresses SHP2-mediated signaling, leading to the inhibition of breast cancer cell phenotypes [1].
Molecular Weight:
398.49
Purity:
99.80%
CAS Number:
[2907659-86-1]
Formula:
C24H30O5
Target:
Phosphatase
T73552
* VAT and and shipping costs not included. Errors and price changes excepted
